Skip to main content
Screener/Healthcare/Biotechnology

CTNM — Contineum Therapeutics, Inc.

NASDAQ
$9.02-4.36 (-32.60%)
$8.60
$17.79
$8.43
$11.54
EPS (TTM)$-1.95
P/E Ratio-6.45
Dividend Yield—
Market Cap$478.5M
Volume6.76M
Prev Close$13.38
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$14.5M$-0.39——
Q4 '25$0-$15.2M$-0.49——
Q3 '25$0-$12.8M$-0.45——
Q2 '25$0-$16.0M$-0.62——
Q1 '25$0-$16.0M$-0.62——
Q4 '24$0-$14.6M$-0.56——
Q3 '24$0-$10.3M$-0.40——
Q2 '24$0-$9.0M$-0.35——
Get Your Daily Market Recap